Cian Healthcare Ltd (CHCL) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Cian Healthcare Ltd reported sales of ₹17 Cr, operating profit of ₹-3 Cr (OPM -18%) and net profit of ₹-18 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.
CHCL quarterly results (₹ Cr) Metric Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Mar 2026 Sales 31 38 31 33 62 19 12 17 Expenses 30 32 24 28 51 20 17 20 Operating Profit 1 5 7 4 11 -1 -5 -3 OPM 2.9% 14% 22% 14% 18% -8% -44% -18% Other Income 0 1 0 0 0 -12 0 -13 Interest 3 3 3 3 6 2 1 0 Depreciation 2 3 3 3 5 2 2 2 Profit before tax -4 0 2 -1 0 -18 -8 -18 Tax -13% -167% 14% 37% -400% 0% 0% 0% Net Profit -4 0 2 -1 0 -18 -8 -18 EPS in Rs -1.54 0.19 0.62 -0.59 0.1 -7.3 -3.09 -7.19
CHCL profit & loss, annual (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sales 74 78 69 62 31 28 Expenses 62 74 56 51 37 35 Operating Profit 12 4 13 11 -7 -7 OPM 16% 6% 19% 18% -21% -23% Other Income 0 0 1 0 -12 -12 Interest 8 7 6 6 3 1 Depreciation 3 4 5 5 4 4 Profit before tax 1 -6 2 0 -26 -23 Tax 91% -8% -2% -1,600% 0% 0% Net Profit 0 -6 2 1 -26 -23 EPS in Rs 0.02 -2.21 0.81 0.34 -10.39 -9.32 Dividend Payout 0% 0% 0% 0% 0% 0%
CHCL balance sheet (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Equity Capital 25 25 25 25 25 Reserves 30 32 33 7 -16 Borrowings 63 61 56 55 29 Other Liabilities 47 42 47 69 24 Total Liabilities 166 160 161 156 62 Fixed Assets 50 45 39 35 32 CWIP 13 14 15 15 6 Investments 5 5 5 5 0 Other Assets 98 97 102 101 23 Total Assets 166 160 161 156 62
CHCL cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 9 5 12 21 -1 Cash from Investing Activity 1 3 -1 0 13 Cash from Financing Activity -11 -7 -10 -4 -28 Net Cash Flow -1 0 0 17 -17 Free Cash Flow 4 4 11 20 7 CFO/OP 197% 37% 106% -315% 22%
CHCL ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 125 140 121 206 163 Inventory Days 300 400 486 420 82 Days Payable 270 296 371 671 219 Cash Conversion Cycle 155 244 236 -45 26 Working Capital Days 38 41 26 -729 -96 ROCE 0% 7% 5% -11% -15%